Marshall Wace, LLP Senseonics Holdings, Inc. Transaction History

Marshall Wace, LLP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$1.02 - $2.23 $306,082 - $669,180	300,081 New	300,081 $396,000
Q2 2021 Aug 13, 2021	SELL	$1.71 - $4.14 $956,577 - $2.32 Million	-559,402 Reduced 88.03%	76,055 $292,000
Q1 2021 May 17, 2021	BUY	$0.85 - $5.27 $540,138 - $3.35 Million	635,457 New	635,457 $1.68 Million
Q2 2019 Aug 14, 2019	SELL	$1.81 - $2.45 $201,272 - $272,440	-111,200 Closed	0 $0
Q1 2019 May 14, 2019	BUY	$2.3 - $3.27 $255,759 - $363,624	111,200 New	111,200 $272,000

140

59.9M

393K

254K

Ticker SENS
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 465,447,008
Market Cap $363M
Description
Senseonics Holdings, Inc., a medical technology company, develops and commercializes continuous glucose monitoring (CGM) systems for people with diabetes in the United States, Europe, the Middle East, and Africa. The company's products include Eversense and Eversense XL, which are implantable CGM systems to measure glucose levels in people with ...

Get notified when there are updates to the investment portfolio of Marshall Wace, LLP, based on Form 13F filings with the SEC.

Stay updated on Marshall Wace, LLP with notifications on news.